Literature DB >> 36001204

Erythropoietin promotes energy metabolism to improve LPS-induced injury in HK-2 cells via SIRT1/PGC1-α pathway.

Kan Li1, Li Gao2, Sen Zhou1, Yan-Rong Ma3, Xiao Xiao4, Qian Jiang4, Zhi-Hong Kang4, Ming-Long Liu1, Tian-Xi Liu5.   

Abstract

Acute kidney injury (AKI) is one of frequent complications of sepsis with high mortality. Mitochondria is the center of energy metabolism participating in the pathogenesis of sepsis-associated AKI, and SIRT1/PGC1-α signaling pathway plays a crucial role in the modulation of energy metabolism. Erythropoietin (EPO) exerts protective functions on chronic kidney disease. We aimed to assess the effects of EPO on cell damage and energy metabolism in a cell model of septic AKI. Renal tubular epithelial cells HK-2 were treated with LPS and human recombinant erythropoietin (rhEPO). Cell viability was detected by CCK-8 and mitochondrial membrane potential was determined using JC-1 fluorescent probe. Then the content of ATP, ADP and NADPH, as well as lactic acid, were measured for the assessment of energy metabolism. Oxidative stress was evaluated by detecting the levels of ROS, MDA, SOD and GSH. Pro-inflammatory cytokines, including TNF-α, IL-6, and IL-1β, were measured with ELISA. Moreover, qRT-PCR and western blot were performed to detect mRNA and protein expressions. shSIRT1 was used to knockdown SIRT1, while EX527 and SR-18292 were applied to inhibit SIRT1 and PGC1-α, respectively, to investigate the regulatory mechanism of rhEPO on inflammatory injury and energy metabolism. In LPS-exposed HK-2 cells, rhEPO attenuated cell damage, inflammation and abnormal energy metabolism, as indicated by the elevated cell viability, the inhibited oxidative stress, cell apoptosis and inflammation, as well as the increased mitochondrial membrane potential and energy metabolism. However, these protective effects induced by rhEPO were reversed after SIRT1 or PGC1-α inhibition. EPO activated SIRT1/PGC1-α pathway to alleviate LPS-induced abnormal energy metabolism and cell damage in HK-2 cells. Our study suggested that rhEPO played a renoprotective role through SIRT1/PGC1-α pathway, which supported its therapeutic potential in septic AKI.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Energy metabolism; Erythropoietin; HK-2 cells; LPS; PGC1-α; Renoprotection; SIRT1

Year:  2022        PMID: 36001204     DOI: 10.1007/s11010-022-04540-y

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.842


  46 in total

Review 1.  A unified theory of sepsis-induced acute kidney injury: inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury.

Authors:  Hernando Gomez; Can Ince; Daniel De Backer; Peter Pickkers; Didier Payen; John Hotchkiss; John A Kellum
Journal:  Shock       Date:  2014-01       Impact factor: 3.454

Review 2.  Apoptosis and acute kidney injury.

Authors:  Andrea Havasi; Steven C Borkan
Journal:  Kidney Int       Date:  2011-05-11       Impact factor: 10.612

Review 3.  Acute Kidney Injury in Sepsis: Evidence From Asia.

Authors:  Kohei Yoshimoto; Yohei Komaru; Masao Iwagami; Kent Doi
Journal:  Semin Nephrol       Date:  2020-09       Impact factor: 5.299

Review 4.  Erythropoietin biology in cancer.

Authors:  Matthew E Hardee; Murat O Arcasoy; Kimberly L Blackwell; John P Kirkpatrick; Mark W Dewhirst
Journal:  Clin Cancer Res       Date:  2006-01-15       Impact factor: 12.531

Review 5.  It Takes Two to Tango: The Role of Dysregulated Metabolism and Inflammation in Kidney Disease Development.

Authors:  Ghazal Z Quinn; Poonam Dhillon; Katalin Susztak
Journal:  Semin Nephrol       Date:  2020-03       Impact factor: 5.299

Review 6.  Acute kidney injury.

Authors:  John A Kellum; Paola Romagnani; Gloria Ashuntantang; Claudio Ronco; Alexander Zarbock; Hans-Joachim Anders
Journal:  Nat Rev Dis Primers       Date:  2021-07-15       Impact factor: 52.329

7.  The hypoxia inducible factor/erythropoietin (EPO)/EPO receptor pathway is disturbed in a rat model of chronic kidney disease related anemia.

Authors:  Daniel Landau; Lital London; Inbar Bandach; Yael Segev
Journal:  PLoS One       Date:  2018-05-08       Impact factor: 3.240

Review 8.  Timing of Initiation of Renal Replacement Therapy in Sepsis-Associated Acute Kidney Injury.

Authors:  José Agapito Fonseca; Joana Gameiro; Filipe Marques; José António Lopes
Journal:  J Clin Med       Date:  2020-05-10       Impact factor: 4.241

9.  IRF1-mediated downregulation of PGC1α contributes to cardiorenal syndrome type 4.

Authors:  Yinghui Huang; Shaobo Wang; Jie Zhou; Yong Liu; Changhong Du; Ke Yang; Xianjin Bi; Mingying Liu; Wenhao Han; Kailong Wang; Jiachuan Xiong; Song Wang; Yue Wang; Ling Nie; Chi Liu; Daohai Zhang; Jun Gu; Chunyu Zeng; Jinghong Zhao
Journal:  Nat Commun       Date:  2020-09-16       Impact factor: 14.919

Review 10.  Impact of Renal Replacement Therapy on Mortality in Critically Ill Patients-The Nephrologist's View within an Interdisciplinary Intensive Care Team.

Authors:  Matthias Klingele; Lea Baerens
Journal:  J Clin Med       Date:  2021-07-30       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.